<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6559D249-3FF9-4728-9104-CBE0181A9E87"><gtr:id>6559D249-3FF9-4728-9104-CBE0181A9E87</gtr:id><gtr:name>Institute of Science and Tech (Austria)</gtr:name><gtr:address><gtr:line1>Am Campus 1</gtr:line1><gtr:line2>3400</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6559D249-3FF9-4728-9104-CBE0181A9E87"><gtr:id>6559D249-3FF9-4728-9104-CBE0181A9E87</gtr:id><gtr:name>Institute of Science and Tech (Austria)</gtr:name><gtr:address><gtr:line1>Am Campus 1</gtr:line1><gtr:line2>3400</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C1348120-7F27-4008-B0FB-45ECF6C547EC"><gtr:id>C1348120-7F27-4008-B0FB-45ECF6C547EC</gtr:id><gtr:firstName>Antal</gtr:firstName><gtr:surname>Rot</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802838"><gtr:id>6306CFCE-016F-4A9D-9EF4-3548008CF2E5</gtr:id><gtr:title>Strategic Appointment of Dr Rot</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802838</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2014-02-02</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-08-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>900002</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>ACR</gtr:description><gtr:id>A61A2ED6-D903-4892-9B13-D4C8F8D02B73</gtr:id><gtr:impact>Several publications and publications in preparation</gtr:impact><gtr:outcomeId>YiZhsiPE4xL-5</gtr:outcomeId><gtr:partnerContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:partnerContribution><gtr:piContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hannover Medical School</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Immunology</gtr:department><gtr:description>ACR</gtr:description><gtr:id>42A69C37-78EE-4224-9DCA-530F2187CFEA</gtr:id><gtr:impact>Several publications and publications in preparation</gtr:impact><gtr:outcomeId>YiZhsiPE4xL-4</gtr:outcomeId><gtr:partnerContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:partnerContribution><gtr:piContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Science and Technology Austria</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>ACR</gtr:description><gtr:id>C5BA9651-8A8A-417A-9D50-8416FB29F980</gtr:id><gtr:impact>Several publications and publications in preparation</gtr:impact><gtr:outcomeId>YiZhsiPE4xL-3</gtr:outcomeId><gtr:partnerContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:partnerContribution><gtr:piContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>ACR</gtr:description><gtr:id>1B59472D-E645-4F30-B6A8-F24BD73547DA</gtr:id><gtr:impact>Several publications and publications in preparation</gtr:impact><gtr:outcomeId>YiZhsiPE4xL-1</gtr:outcomeId><gtr:partnerContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:partnerContribution><gtr:piContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>ACR</gtr:description><gtr:id>6ABADC94-A453-4A3B-840C-20D069ED819D</gtr:id><gtr:impact>Several publications and publications in preparation</gtr:impact><gtr:outcomeId>YiZhsiPE4xL-2</gtr:outcomeId><gtr:partnerContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:partnerContribution><gtr:piContribution>Elucidating the pathophysiology of the atypical chemokine receptors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>209000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Marie Curie FELLOWSHIP</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>E90C707C-9DAA-46FF-B075-0390BF9FC07F</gtr:id><gtr:outcomeId>rfxsdTmG8Gm</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>203537</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9814AAFF-A239-49D8-A6EB-C98D7A01806E</gtr:id><gtr:outcomeId>fSRJb5JnE2a0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Initial Training Network</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>DECIDE</gtr:fundingRef><gtr:id>C67C65C7-4A61-457B-B90F-4330839A539B</gtr:id><gtr:outcomeId>eFU65Ak3rWv</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>&amp;quot;Caucasian&amp;quot; counterpart to the &amp;quot;West African&amp;quot; polymorphism</gtr:description><gtr:id>D3220A15-56B2-4B3F-BC48-9291C8D94F29</gtr:id><gtr:impact>Control polymorphism</gtr:impact><gtr:outcomeId>BE7WAQxdAik</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>huDARC &quot;Caucasian Polymorphism Mouse&quot;</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mouse expressing West African Polymorphic variant of DARC FyB(ES) gene</gtr:description><gtr:id>A48A20B0-B15C-4543-8DD3-F32F1C824AF8</gtr:id><gtr:impact>Ability to dissect the in vivo mechanism of chemokine patterning in individuals of West African origin affecting many diseases prevalent in these individuals</gtr:impact><gtr:outcomeId>fdy6MferWTU</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>huDARC &quot;West African Polymorphism Mouse&quot;</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>90B6483E-9535-4738-A3CE-340235FB2EDD</gtr:id><gtr:title>The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af864607240255e91efccd46a80dec8d"><gtr:id>af864607240255e91efccd46a80dec8d</gtr:id><gtr:otherNames>Ulvmar MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_540e168e168bba676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>498E5D4A-41B8-4331-B204-BC2C5F9F53DA</gtr:id><gtr:title>New nomenclature for atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_540e168e168a71a62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAC26CA1-E7C1-4C9E-A8CD-A734904616EF</gtr:id><gtr:title>High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fef93a0cba926c4991621c5e7bc22459"><gtr:id>fef93a0cba926c4991621c5e7bc22459</gtr:id><gtr:otherNames>Sallmann E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16140_20_21622859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F10C0AD-DABD-43A9-AC37-90396D3DDD49</gtr:id><gtr:title>CD8 T cells induce T-bet-dependent migration toward CXCR3 ligands by differentiated B cells produced during responses to alum-protein vaccines.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_16140_20_23065152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>535C98D8-AD70-4480-8E3F-07A787C89709</gtr:id><gtr:title>CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2ddf28a176bf0f756427edbddb9f2ee"><gtr:id>e2ddf28a176bf0f756427edbddb9f2ee</gtr:id><gtr:otherNames>Lucas B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>doi_55f9859850b807d7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D42A3920-A5E3-46C4-BFBC-34F93D1EE0A9</gtr:id><gtr:title>The biochemistry and biology of the atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f176dd01922419b3d1012bc2a4437f53"><gtr:id>f176dd01922419b3d1012bc2a4437f53</gtr:id><gtr:otherNames>Graham GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn><gtr:outcomeId>pm_16140_20_22698181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B548B6C-8031-4342-8DA8-E479CAAD0903</gtr:id><gtr:title>Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/612e61bacb57083651200ef327198bca"><gtr:id>612e61bacb57083651200ef327198bca</gtr:id><gtr:otherNames>Madigan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16140_20_20147628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF1BF41E-6558-45C5-8517-CE1E3CDEC903</gtr:id><gtr:title>DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a67677116e4da306e94c57ba7effc80"><gtr:id>9a67677116e4da306e94c57ba7effc80</gtr:id><gtr:otherNames>Minten C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e168e168b24d5f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D00FAD65-F734-4A56-A63D-AE80FC82078D</gtr:id><gtr:title>International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn><gtr:outcomeId>545cff19e9bf10.99255248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60FECC7F-2A4A-4262-92DE-443E3855BF1B</gtr:id><gtr:title>Atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af864607240255e91efccd46a80dec8d"><gtr:id>af864607240255e91efccd46a80dec8d</gtr:id><gtr:otherNames>Ulvmar MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>pm_16140_20_21272574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68161FCA-608E-4B7C-BE50-5C800E1C037C</gtr:id><gtr:title>An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31595901068cb85fb01f0fc33821a6c2"><gtr:id>31595901068cb85fb01f0fc33821a6c2</gtr:id><gtr:otherNames>Bachelerie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>5675e42986cce</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1618CB26-24AD-4CF2-A688-0D4AF323F8DF</gtr:id><gtr:title>Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c042d7437f5460e147b6334c0038e322"><gtr:id>c042d7437f5460e147b6334c0038e322</gtr:id><gtr:otherNames>Baldwin HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545cff19c07f27.85780458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B87FA7D-4ECB-456B-9B59-5A353896C3D3</gtr:id><gtr:title>Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd8ffde85da8deb5a4a225986f8a4881"><gtr:id>bd8ffde85da8deb5a4a225986f8a4881</gtr:id><gtr:otherNames>Singh MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>pm_16140_20_22867710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0442E9B-9530-4752-94FB-735FC1444511</gtr:id><gtr:title>CXCR7 functions as a scavenger for CXCL12 and CXCL11.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ad1f36b399b3bf5a5f2f100e891b5c8"><gtr:id>7ad1f36b399b3bf5a5f2f100e891b5c8</gtr:id><gtr:otherNames>Naumann U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16140_20_20161793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D54E925-195A-444E-A427-AF5889FEBA2F</gtr:id><gtr:title>Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ba21f3dc54ecb9c9218e24bf85e9dc2"><gtr:id>4ba21f3dc54ecb9c9218e24bf85e9dc2</gtr:id><gtr:otherNames>Duchene J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5a35b00b4ada58.08805462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59D669A6-095D-40E9-97F9-6373ED5F3331</gtr:id><gtr:title>Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9bc237928e12718967f650336bef70e"><gtr:id>a9bc237928e12718967f650336bef70e</gtr:id><gtr:otherNames>Novitzky-Basso I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>doi_16140_2012_00266</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802838</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>